Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Turning Point Launches IPO, Stock Rises 60% On First Day

Apr 17 2019

• By Mandy Jackson

Finance Watch

Related Content

Trevi Therapeutics Goes Up Against Cara In Itch

Sep 15 2015

Fovista AMD Failure Puts Eylea In The Clear, Blurs Anti-PDGF Prospects

Dec 13 2016

Finance Watch: Surrozen Raises $33m In $483m February Flurry; Also, Are Reverse Mergers This Year's IPOs?

Feb 28 2017

Finance Watch: Genfit Launches IPO To Expand US Presence Ahead Of Phase III NASH Results

Mar 28 2019

A Trough Year For Teva, With A Turning Point Targeted For 2020

Feb 13 2019

Finance Watch: Gossamer, Alector And Harpoon Launch First Biopharma IPOs Of 2019

Feb 09 2019

Finance Watch: Genocea, Mateon Shift Strategies, Cut Jobs To Preserve Cash

Sep 28 2017

Chi-Med Files For Hong Kong Listing That Could Raise $500m

Apr 16 2019

Finance Watch: NGM Bio Is Second NASH IPO In Two Weeks

Apr 05 2019

Keeping Track: FDA Starts November With A Bang

Nov 02 2018

X4 Pharmaceuticals Inc.

Mar 08 2016

Finance Watch: Six More IPO Filings As Three More Biopharmas Go Public In The US

May 27 2018

Cure Pharmaceutical Targets Rx Entry For Film Strip While Now Focused On Supplements

Oct 05 2018

Finance Watch: Rough US Stock Market Doesn't Stop Biopharma IPOs As Six More Go Public

Oct 31 2018

Roche’s Entrectinib Differentiates Itself From NSCLC Competitors With CNS Data

Sep 24 2018

Hong Kong Ushers in 'New Era' For Bioventures As Listing Rules Eased

May 02 2018

Novartis commits $1bn for ex-US rights to Ophthotech AMD drug

May 20 2014

Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

Dec 18 2018

Finance Watch: Moderna Launches Biggest Biopharma IPO Ever As US Market Resets Expectations

Dec 11 2018

Deal Watch: Boehringer Teams Up In CNS Disorders Again, This Time With Domain

Dec 06 2018

Finance Watch: Investors Can't Get Enough Of NASH, Including Start-Ups With Novel Drugs

Nov 02 2018

Finance Watch: Alphamab's $100m Series A Continues Theme Of Big Investments In China Biopharma

Nov 23 2018

NextCure Hopes Its Novel Target Therapies Will Treat Patients Not Helped By PD-1/L1 Inhibition

Nov 28 2018

Venture Funding Deals: Two Companies With China Ties Raise $260m Each

Jun 05 2018

Finance Watch: Is The IPO Boom Making Anyone Nervous Yet?

Jun 28 2018

IPO Update: Will Declining Returns Slow Fast Pace Of Biopharma Offerings?

Apr 03 2018

Related Companies

NGM Biopharmaceuticals, Inc.

HOOKIPA Pharma Inc.

Turning Point Therapeutics Inc.

Pfizer Inc.

Merck KGaA

Trevi Therapeutics, Inc.

Axcella Therapeutics, Inc.

Applied Therapeutics Inc.

Quince Therapeutics, Inc.

Milestone Pharmaceuticals, Inc.

NextCure, Inc.

HUTCHMED (China) Limited

Achaogen, Inc.

Iveric Bio, Inc.

Novartis AG

Gilead Sciences, Inc.

Homology Medicines, Inc.

Autolus Therapeutics plc

Rocket Pharmaceuticals Inc.

Inotek Pharmaceuticals Corporation

Teva Pharmaceutical Industries Ltd.

TherapeuticsMD Inc.

X4 Pharmaceuticals, Inc.

Sanofi

Additional Topics

Financing Business Strategies Deals Commercial Cancer BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.